Annual Cash & Cash Equivalents
$20.10B$4.42B-18.02%
Summary
- Current Value
- As of today, JNJ annual cash & cash equivalents is $20.10B, down -18.02% on
- Historical Performance
- JNJ annual cash & cash equivalents is down -9.78% over the past 3 years, down -20.18% over the past 5 years
- All-Time High Comparison
- JNJ annual cash & cash equivalents is currently -52.03% below its historical high of $41.91B set on
- 3-Year Low Comparison
- JNJ annual cash & cash equivalents is at its 3-year low
- Sector Comparison
- JNJ annual cash & cash equivalents is higher than 99.91% of companies in Healthcare sector
Cash and Cash Equivalents Chart
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual Cash & Cash Equivalents | $20.10B | -18.0% | -9.8% | -20.2% | -27.3% | |
| Quarterly Cash & Cash Equivalents | $22.05B | -43.1% | -31.8% | -10.4% | -17.9% | |
| Price | $234.20 | +55.4% | +42.6% | +44.6% | +253.3% | |
| Annual Current Assets | $55.62B | -0.5% | +0.6% | +8.6% | +17.6% | |
| Annual Total Liabilities | $117.67B | +8.3% | +6.4% | +5.4% | +154.0% | |
| Annual Working Capital | $1.50B | -73.1% | +394.9% | -82.9% | -93.8% | |
| Annual Net Income | $26.80B | +90.6% | +63.7% | +82.2% | +101.0% |
Cash and Cash Equivalents Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $24.52B | -18.0% | |
| 5Y | $31.61B | -36.4% | |
| All | $41.91B | -52.0% |
Cash and Cash Equivalents Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $20.10B | at low | |
| 5Y | $20.10B | at low | |
| All | $442.50M | +4442.8% |
Cash and Cash Equivalents History
FAQ
What is the current annual cash & cash equivalents of JNJ?
As of today, JNJ annual cash & cash equivalents is $20.10B
What is 1-year change in JNJ annual cash & cash equivalents?
JNJ annual cash & cash equivalents is down -18.02% year-over-year
What is 3-year change in JNJ annual cash & cash equivalents?
JNJ annual cash & cash equivalents is down -9.78% over the past 3 years
How far is JNJ annual cash & cash equivalents from its all-time high?
JNJ annual cash & cash equivalents is currently -52.03% below its historical high of $41.91B set on December 1, 2016
How does JNJ annual cash & cash equivalents rank versus sector peers?
JNJ annual cash & cash equivalents is higher than 99.91% of companies in Healthcare sector
When is JNJ next annual earnings release?
As of today, the next annual earnings release for JNJ has not been scheduled
Cash and Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
Quarterly Cash & Cash Equivalents
$22.05B$1.95B+9.70%
Summary
- Current Value
- As of today, JNJ quarterly cash & cash equivalents is $22.05B, up +9.70% on
- Historical Performance
- JNJ quarterly cash & cash equivalents is down -43.14% year-over-year, down -31.75% over the past 3 years
- All-Time High Comparison
- JNJ quarterly cash & cash equivalents is currently -48.22% below its historical high of $42.58B set on
- 3-Year Low Comparison
- JNJ quarterly cash & cash equivalents is +18.80% above its 3-year low of $18.56B reached on
- Sector Comparison
- JNJ quarterly cash & cash equivalents is higher than 99.91% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly Cash & Cash Equivalents | $22.05B | +9.7% | -43.1% | -31.8% | -10.4% | |
| Annual Cash & Cash Equivalents | $20.10B | – | -18.0% | -9.8% | -20.2% | |
| Price | $234.20 | -1.3% | +55.4% | +42.6% | +44.6% | |
| Quarterly Current Assets | $59.17B | +6.4% | -17.3% | -8.1% | +12.6% | |
| Quarterly Total Liabilities | $119.71B | +1.7% | +3.6% | -4.3% | +12.2% | |
| Quarterly Working Capital | $1.46B | -2.7% | -90.0% | -63.7% | -87.4% | |
| Quarterly Net Income | $5.24B | +2.3% | -52.4% | +1166.2% | -15.5% |
Quarterly Cash & Cash Equivalents Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $38.78B | N/A | -43.1% |
| 3Y | $38.78B | -43.1% | |
| 5Y | $38.78B | -43.1% | |
| All | $42.58B | -48.2% |
Quarterly Cash & Cash Equivalents Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $18.56B | +18.8% | |
| 3Y | $18.56B | +18.8% | |
| 5Y | $18.56B | +18.8% | |
| All | $334.00M | +6502.1% |
Quarterly Cash & Cash Equivalents History
FAQ
What is the current quarterly cash & cash equivalents of JNJ?
As of today, JNJ quarterly cash & cash equivalents is $22.05B
What is JNJ quarterly cash & cash equivalents most recent change?
JNJ quarterly cash & cash equivalents was up +9.70% on March 31, 2026
What is 1-year change in JNJ quarterly cash & cash equivalents?
JNJ quarterly cash & cash equivalents is down -43.14% year-over-year
How far is JNJ quarterly cash & cash equivalents from its all-time high?
JNJ quarterly cash & cash equivalents is currently -48.22% below its historical high of $42.58B set on June 1, 2016
How does JNJ quarterly cash & cash equivalents rank versus sector peers?
JNJ quarterly cash & cash equivalents is higher than 99.91% of companies in Healthcare sector
When is JNJ next earnings release?
The next earnings release for JNJ is on
Cash and Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
Data Sources & References
- JNJ Official Website www.jnj.com
- JNJ Profile on Yahoo Finance finance.yahoo.com/quote/JNJ
- JNJ Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/jnj